This slideshow takes a look at some of the top kidney cancer news of 2016, including FDA approvals, survival disparities, surgical approaches, and more.
TFS Improves With Nivolumab, Salvage Nivolumab in Advanced Renal Cell Carcinoma
February 21st 2023Results from cohort A of the HCRN GU16-260 trial showed treatment-free survival was enhanced in patients with advanced renal cell carcinoma who received nivolumab monotherapy plus salvage nivolumab and ipilimumab maintenance.
PET/CT Imaging Agent Demonstrates Real-World Specificity/Sensitivity in RCC
February 20th 202389Zr-DFO-girentuximab improves sensitivity and specificity in identifying clear cell kidney cancer compared with any metric to date, according to an expert from the University of California, Los Angeles.
2 Clarke Drive
Cranbury, NJ 08512